Status:
COMPLETED
The Utility of Levofloxacin-Rifampin in the Therapy of Prosthetic Joint Infection
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
Ortho-McNeil, Inc.
Conditions:
Staphylococcal Infection
Staphylococcus Aureus Prosthetic Joint Infection
Eligibility:
All Genders
18+ years
Brief Summary
Prosthetic joint infection is a devastating complication of total joint arthroplasty ultimately leading to the failure of the total joint arthroplasty function and possibly death. Optimal treatment re...
Eligibility Criteria
Inclusion
- A maximum of 15 adult participants with total hip or total knee arthroplasty are approved for enrollment in this protocol at Mayo Clinic Rochester.
Exclusion
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2007
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00279864
Start Date
September 1 2005
End Date
January 1 2007
Last Update
April 30 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905